System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

JBIO

$13.92+0.43%

Jade Biosciences Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

75Ripe

Live Analysis Active

Company Mission

Jade Biosciences Inc creates new medicines for rare diseases that affect small patient groups. Doctors and hospitals use these drugs to treat conditions with few other options. The company makes money by selling these treatments after they pass clinical trials and get approved, and through deals with bigger drug makers.

JBI

Industry Context

Jade Biosciences operates in the biotechnology sector, focusing on developing treatments for rare diseases. This niche market often faces less competition, allowing for stronger pricing power and faster regulatory pathways.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

84Matrix

Market Momentum

44.3— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

0.43%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing JBIO across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:56 AM UTC

Develops innovative drugs for rare diseases, generating revenue through successful clinical trials and partnerships with larger pharmaceutical companies.

Volume spiked 3x at $15, indicating institutional interest because positive trial results often attract big investors. Monitor if it holds above this level.

Industry expansion in biotechnology is driving strength, with price holding above $12, signaling potential growth as funding for rare disease research increases. Watch for sector momentum.

Breaking out above $18 resistance is forming near , suggesting bullish momentum as breakthrough therapies gain regulatory approvals. Watch for price breaking .

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...